GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » YSB Inc (HKSE:09885) » Definitions » Debt-to-Asset

YSB (HKSE:09885) Debt-to-Asset : 0.04 (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is YSB Debt-to-Asset?

YSB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was HK$110 Mil. YSB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was HK$139 Mil. YSB's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2024 was HK$6,935 Mil. YSB's debt to asset for the quarter that ended in Dec. 2024 was 0.04.


YSB Debt-to-Asset Historical Data

The historical data trend for YSB's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

YSB Debt-to-Asset Chart

YSB Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Asset
0.10 0.05 0.04 0.04 0.04

YSB Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Debt-to-Asset Get a 7-Day Free Trial 0.04 0.04 0.04 0.04 0.04

Competitive Comparison of YSB's Debt-to-Asset

For the Pharmaceutical Retailers subindustry, YSB's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


YSB's Debt-to-Asset Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, YSB's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where YSB's Debt-to-Asset falls into.


;
;

YSB Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

YSB's Debt-to-Asset for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(110.481 + 138.836) / 6934.644
=0.04

YSB's Debt-to-Asset for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(110.481 + 138.836) / 6934.644
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


YSB  (HKSE:09885) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


YSB Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of YSB's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


YSB Business Description

Traded in Other Exchanges
Address
No. 8 Brand Street, No. 397 Xingang Middle Road, Yaoshibang Building, TIT Creative Industry Zone, Guangzhou, CHN
YSB Inc is a digital pharmaceutical platform serving businesses outside of hospitals in China. The Company is committed to using digitalization to empower participants in the out-of-hospital pharmaceutical market, including pharmaceutical companies, distributors, vendors, pharmacies and primary healthcare institutions, and strives to bring pharmaceutical health products and services to the downstream safely and efficiently, so that users can easily obtain a large number of comprehensive and high-quality drugs at a fair and transparent price. It has turned the process of pharmaceutical transaction and service into a digitalized, standardized and scalable one.
Executives
Zhang Buzhen 2501 Other
Chen Xiaohong 2201 Interest of corporation controlled by you
H Capital V, L.p. 2101 Beneficial owner
H Capital V Gp, Ltd. 2201 Interest of corporation controlled by you
H Capital V Gp, L.p. 2201 Interest of corporation controlled by you
Shleifer Scott 2201 Interest of corporation controlled by you
Internet Fund Holding V. Ltd. 2201 Interest of corporation controlled by you
Tiger Global Management, Llc 2102 Investment manager
Tiger Global Pip Performance Xi, L.p. 2201 Interest of corporation controlled by you
Tiger Global Private Investment Partners Xi, L.p. 2101 Beneficial owner
Coleman Iii Charles 2201 Interest of corporation controlled by you
Miyt Worldwide Limited 2201 Interest of corporation controlled by you
Tmf (cayman) Ltd. 2301 Trustee
Internet Fund V Pte. Ltd. 2306 Nominee for another person
Miyt Holdings Limited 2101 Beneficial owner

YSB Headlines

No Headlines